Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.

The mechanisms of p53-dependent apoptosis involve a set of genes that possess the ability to modulate oxidative stress. One of them PIG3, is induced by p53 through a microsatellite in its promoter region. This microsatellite was found to acquire its full structure and p53-functional dependence only in Hominoidea (apes and humans) and has been proposed to represent an evolutionary adaptation of tumor suppressor mechanisms. Microsatellite instability and genetic constitution, comprising the presence of the low repetition allele (10 TGYCC repeats), at this locus have been hypothesized to provide an increased risk for cancer development. Therefore, in the present analysis we examined this polymorphism in two common human cancers, lung and breast and compared it with corresponding control cases. Furthermore, for lung cancer we employed two different ethnic groups, Greek and British. Analysis of this locus in this types of tumors showed: (1) a very low frequency of microsatellite instability and loss of heterozygosity (1.4% and 4%, respectively) in the examined carcinomas, (2) the homozygous presence of the 10 repeats allele only in the control cases, and (3) a non-significant increase of the most frequent allele (15 repeats) in the cancer groups as compared to control ones. The last two observations were found in both Greek and British populations. Taken together, these data do not support the notion that this PIG3 polymorphism is associated with an increased risk for cancer susceptibility. Larger studies including other types of cancer should also be performed.

[1]  A. Contente,et al.  Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain , 2000, Oncogene.

[2]  Xinbin Chen,et al.  Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes , 2004, Oncogene.

[3]  V. Gorgoulis,et al.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. , 2002, The American journal of pathology.

[4]  Judith Roth,et al.  A polymorphic microsatellite that mediates induction of PIG3 by p53 , 2002, Nature Genetics.

[5]  B. Vogelstein,et al.  p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. , 2000, Cancer letters.

[6]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[7]  A. Lasa,et al.  Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias , 2004, Leukemia.

[8]  H. Kovar,et al.  Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y. , 2004, Molecular cancer research : MCR.

[9]  A. Papavassiliou,et al.  p53 activates ICAM‐1 (CD54) expression in an NF‐κB‐independent manner , 2003 .

[10]  V. Zoumpourlis,et al.  Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. , 2001, Cancer genetics and cytogenetics.

[11]  N. Holbrook,et al.  Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.

[12]  Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer , 2001, Breast Cancer Research.

[13]  C. Nicholls,et al.  UV-dependent Alternative Splicing Uncouples p53 Activity and PIG3 Gene Function through Rapid Proteolytic Degradation* , 2004, Journal of Biological Chemistry.

[14]  A. Contente,et al.  A promoter that acquired p53 responsiveness during primate evolution. , 2003, Cancer research.